LegalHerald.com reports on the outcomes of four Risperdal lawsuits which all similarly allege that use of the antipsychotic caused gynecomastia (male breast growth) in the plaintiffs. Of the four complaints, plaintiffs have won three. The fourth was won by defendant Janssen, a subsidiary of Johnson & Johnson when the Philadelphia jury decided that although the company was negligent in labeling the product there was not sufficient evidence to prove that the drug caused the plaintiff’s gynecomastia
The first case to go to court awarded the plaintiff, who began taking Risperdal in 2002 to treat his mood swings, $2.5 million. According to court documents, he had developed size 46DD breasts and testimony from a J&J biochemist during the trial revealed that the company hid the known risk of a gynecomastia side effect.
One of the more recent lawsuits awarded the plaintiff $500,000 after he used Risperdal beginning at the age of 12, from 2006 to 2009 to treat his Tourette syndrome. He reportedly gained 60 pounds and developed breasts. The plaintiff lost the additional weight yet his gynecomastia condition remained and he was bullied in high school. He underwent breast reduction surgery at the age of 18.
The third trial in which the jury found favor with the plaintiff determined that Johnson & Johnson would be required to pay the plaintiff $1.7 million for mental anguish and disfigurement. The plaintiff, in this case, had used Risperdal beginning at the age of 9 to treat schizophrenia despite the fact that the FDA had not approved the drug for use in children at that time.
The results of these lawsuits give hope to the plaintiffs in over 1,600 cases that await trial, which all commonly allege that Janssen failed to warn consumers of the potential side effects of Risperdal. As these cases await trial, the attorneys of Banville Law are working to ensure that anyone who has taken Risperdal and has suffered from adverse effects that they attribute to their use of the drug will be given the opportunity to evaluate their legal rights. Those individuals may be entitled to significant compensation. The firm is currently offering free legal consultations to qualified parties.
To ask questions or obtain more information on Risperdal lawsuits, please contact Banville Law at (888) 997-3792.
Banville Law is a New York law firm dedicated to assisting plaintiffs in lawsuits involving personal injury, product liability and related legal matters.
165 West End Avenue, #1H
New York, NY 10023
United States (US)
April 29, 2016 – Risperdal Lawsuit Allegations Draw Concern Over Possible Gynecomastia Side Effect
April 29, 2016 – Mother Files Risperdal Lawsuit Claiming Drug Caused Development Of Son’s Gynecomastia
April 29, 2016 – Risperdal Plaintiff Awarded $1.75 Million In Damages
April 28, 2016 – Risperdal Lawsuit Plaintiffs Are Awarded $8 Million After The Death Of A Family Member
April 28, 2016 – Millions Awarded To Plaintiffs In Risperdal Lawsuit Verdicts
April 28, 2016 – Risperdal Lawsuit Trial Draws Attention To Controversial Testimony And Potentially Hidden Study Results
April 27, 2016 – Risperdal Lawsuit Plaintiffs Observe As Millions Paid Out For Risperdal Jury Verdicts
April 27, 2016 – Louisiana Risperdal Lawsuit Plaintiff Claims Drug Caused Son’s Gynecomastia Development
April 27, 2016 – U.S. Supreme Court Shows Favor To Risperdal Lawsuit Plaintiffs
April 26, 2016 – Johnson & Johnson Subsidiary Janssen Pharmaceuticals Loses Third Risperdal Lawsuit